Skip to main content

Andrew Hulsh


[email protected]



Andrew is a trusted and sought-after transactional attorney with extensive experience leading US and cross-border M&A buyout transactions and growth equity investments on behalf of private equity sponsors and their portfolio companies. Andrew also regularly represents publicly listed and privately held companies in connection with strategic M&A transactions involving clients and target companies based in the United States and throughout Europe, Latin America and Asia. He has significant experience advising clients connected to and on deals involving life sciences, technology, renewable energy, health care, telecommunications, business services, and aviation.

Andrew has also represented issuers and underwriters in capital markets transactions involving more than 100 initial and secondary public offerings, as well as leading venture funds and emerging companies in numerous early and later-stage venture capital investments.  

In addition, Andrew has an active investment funds practice in which he advises both emerging and established fund managers in connection with the formation of private equity and venture capital funds, fund-to-fund investments, co-investments, and the acquisition of asset managers.

Andrew is a regular contributor to leading news and information outlets such as CNBC, The Wall Street Journal, Bloomberg News, Buyouts, Dow Jones Newswire, Law360, Thomson Reuters, and The Deal. His articles on private equity, M&A, board fiduciary duties and asset management have been published in leading books, journals, and periodicals. In addition, over the past two decades, Andrew has lectured and presented at more than 50 conferences throughout the United States, Canada, Europe, and South America.

For more than six years, Andrew served on the board of directors of a leading, Nasdaq-listed international telecommunications company.

Prior to joining Mintz, Andrew was a partner at a prominent national law firm, where he led US and cross-border transactions for private equity and venture capital sponsors, publicly-listed companies, and privately-held companies. Earlier, he was the co-leader of the North American private equity practice of a leading global law firm.

* Not admitted to practice in Florida. Admitted to practice only in the State of New York.


Private Equity

  • Represented Cerberus in connection with its $1.5B leveraged acquisition of a major government defense contractor whose shares were publicly traded on the New York Stock Exchange.
  • Represented Francisco Partners in connection with four concurrent acquisitions of technology companies based in the U.S., the United Kingdom, France, and the Netherlands  
  • Represented Francisco Partners in connection as lead investor in the Series D and Series E preferred equity financings rounds of Kyruus, Inc.
  • Represented an Australia-based health care technology company in its acquisition by a major US-based private equity firm.
  • Represented Three Hills Capital Partners, a private equity sponsor based in the United Kingdom and Italy, in connection with its acquisition of a premier U.S.-based restaurant group.
  • Advised several private equity firms focused on the renewable energy space in investment transactions and acquisitions.
  • Represented HPH Specialized Fund I in connection with its leveraged acquisition of a leading nutraceutical company.
  • Represented Signet Healthcare Partners in connection with a substantial growth equity financing of a fully vertically integrated generic pharmaceutical company, with participation across the value chain from intermediates, active pharmaceutical ingredients, and drug product manufacturing. 
  • Represented General Atlantic in connection with growth equity investment in a financial advisory firm.
  • Represented a private equity firm in a significant growth equity investment in a US-based company that concentrates on the development, manufacturing, and commercialization of generic pharmaceutical products.
  • Advised a private equity firm consortium in the hostile takeover of a national security services company.
  • Advised a clinical education technology company offering medical simulation solutions in the sale of the company to a private equity portfolio company that is the world’s leading manufacturer and marketer of anatomical models and medical simulation products used for health care and patient education.
  • Represented a financial sponsor in the standby purchase of common stock issued by a publicly held advertising agency in connection with that company’s emergence from Chapter 11 bankruptcy proceedings.

Strategic Mergers and Acquisitions

  • Advised one of the largest independent hotel, resort, and casino management and development firms in the United States in a joint venture with another leading independent developer, which involved a publicly registered dividend distribution, term loan, and private equity financing.
  • Represented a publicly held international telecommunications company in multiple mergers and acquisitions throughout Latin America.
  • Represented a major publicly held global staffing company in connection with a “merger of equals” with another publicly held global staffing and outsourcing company.
  • Represented a major consumer products company in its acquisition — through a tender offer — of a large medical device company.
  • Advised a global provider of overhaul and maintenance services for gas turbine engines in its acquisition of a UK-based company that provides aftermarket supply-chain management services for the aerospace, defense, and marine industries.
  • Represented a manufacturer of industrial and transportation products in the sale of a Czech Republic–based heavy-duty truck manufacturer to a NYSE-listed multinational conglomerate.
  • Represented a French investment banking firm in connection with the restructuring and sale of a specialty telecommunications company.
  • Represented a publicly held telecommunications company in its acquisition by, and merger with, a major global telecommunications services company.
  • Represented a Russian holding company in multiple mergers and acquisitions throughout Russia, the CIS, Europe, and the United States.
  • Represented a publicly held company in numerous mergers and acquisitions in the renewable energy sector.
  • Advised a publicly held subsidiary of an alternative energy company in connection with a $2.1 billion merger with another public company.

Capital Markets Transactions

  • Represented a global investment bank in a $2 billion sovereign debt offering.
  • Represented a global provider of overhaul and maintenance services for gas turbine engines in the financing of its acquisition of a UK-based provider of aftermarket supply chain management services for the aerospace, defense, and marine industries through a contemporaneous public offering of common stock and senior notes.
  • Represented a global human capital management company in its concurrent public offering of common stock and convertible subordinated notes.
  • Advised a major UK recruitment agency in connection with its spin-off from a NYSE-listed company as well as a public offering and listing of what was, at the time, the largest-ever listing on the London Stock Exchange.
  • Represented a telecommunications company based in Latin America in its issuance and sale of senior subordinated notes in a 144A offering.
  • Represented a “bulge bracket” investment banking firm in the initial public offering of the common shares of a global supplier of aftermarket aircraft engines, engine parts, and airframe components.
  • Advised a “bulge bracket” investment banking firm in its transition from a private partnership to a leading publicly held company, which included the initial and secondary public offerings of its common shares and listing on the NYSE.
  • Advised a real estate development company based in China in its initial public offering and Nasdaq listing.
  • Represented several Special Purpose Acquisition Corporations (SPACs) in their initial public offerings and subsequent M&A transactions.

Venture Capital Transactions

  • Represented a leading private equity and venture capital sponsor in a $30 million investment in Series D Preferred Shares of a Boston-based technology company.
  • Represented a major venture capital fund in more than 40 preferred equity and convertible note investments in technology and life sciences companies based in the United States and throughout Europe.
  • Represented a leading genetics testing company in connection with multiple Series Seed, Series A, and convertible debt financings.
  • Represented a provider of predictive disease models and tissue-specific extracellular matrix (ECM) products in Series Seed and Series A investments.
  • Represented several venture capital funds in early-stage investments in a major regional airline.

Fund Formation and Related Transactions

  • Advising an investment manager focused on the nutraceutical sector in the formation of its second private equity fund following representation of the company in connection with its inaugural fund.
  • Advising a $100 million venture debt fund investing in start-up and early stage companies operating in the “urbantech” sector, which includes, but is not limited to, infrastructure, local services, built environment, real estate, transportation, logistics, food, water, waste, energy and public health, safety, and administration.
  • Represented a financial institution, including two leading Chinese companies and a US-based entity, in connection with the formation of a $2.5 billion private equity fund.
  • Represented an investment manager in the formation of three venture capital funds focused on investments in oncology and cancer research companies.
  • Represented a global private equity sponsor in a $450 million equity investment in a multinational asset manager with operations in Hong Kong, Singapore, German, France, and the United States.
  • Represented a major global insurance company in the acquisition of a hedge fund complex with $22 billion of combined assets under management.
Read less

News & Press

Press Release Thumbnail

Mintz’s Energy & Sustainability practice continued its commitment to energy transition with more than 80 deal closings totaling $4 billion over the past 12 months, as global investment in energy transition showed continued strength in an overall down market.

Press Release Thumbnail

Mintz proudly announced the election of 13 attorneys to Members and the addition of a record-setting 22 new lateral Members in 2023, with 11 Partners in the newly opened Toronto office. This diverse group strengthens Mintz’s core areas, spanning Commercial and IP Litigation, Life Sciences, Tech, Private Equity, and Energy & Sustainability. The elevated Members and new lateral additions bring invaluable expertise to help clients navigate complex legal landscapes. 

News Thumbnail

Law360 featured the arrival of Private Equity Member Andrew Hulsh.

News Thumbnail

The Deal highlighted the arrival of New York Private Equity Member Andrew Hulsh.

News Thumbnail

JD Journal featured the arrival of New York Private Equity Member Andrew Hulsh.

Press Release Thumbnail

Mintz is pleased to announce that Andrew Hulsh, a leading private equity attorney with a particular focus on renewable energy and life sciences, has joined the firm as a Member in its New York office.

News Thumbnail

New York Private Equity Member Andrew Hulsh's arrival was featured in Reuters. The article highlighted the continual growth of Mintz's private equity team.

Read less

Events & Speaking


Investing in US Private Equity

12th Annual Private Equity New York Forum

Conference Reference Image

Private Equity New York Forum

University Club of New York

Conference Reference Image

Investing in U.S. Private Equity — Energy Sector Focus

10th Annual Private Equity New York Forum

Conference Reference Image

Keynote Panel: U.S. Private Equity Outlook

4th Annual Private Equity U.S. Fall Forum

Conference Reference Image
Conference Reference Image

Columbia Business School Private Equity Breakfast

Columbia Business School Alumni Club of New York

Conference Reference Image
Read less

Recognition & Awards

  • The Legal 500: Major Attorney - Large Deals for mergers, acquisitions, and buyouts

  • The Legal 500 Latin America: Corporate and M&A

Read less


  • 5th Annual Global Private Equity Forum, San Francisco: Global Private Market Investing
  • 2021 ACG New York 17th Annual M&A DealSource and Value Creation Summit
  • Ninth Annual Private Equity U.S. New York Forum: Investing in Technology Companies
  • 2022 San Francisco Global Private Equity Forum: Investing in Clean Energy Sector
Read less